| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |